OM

What one share of Outset Medical holds

Electromedical and Electrotherapeutic Apparatus

Outset is a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity. We believe the Tablo® Hemodialysis System (Tablo) represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers.

Outset Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$6.46
Profit−$4.08
Capex (buildings and equipment)$0.03
Free cash flow−$2.13
Cash and investments$1.86
Debt$5.29
Book value$5.13

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2021$33.76−$43.41$1.02−$43.88—$118.78
2022$35.93−$50.75$2.59−$47.98—$76.13
2023$39.45−$52.28$1.04−$40.79—$36.63
2024$32.83−$36.96$0.26−$33.85—$7.60
2025$7.85−$5.37$0.05−$3.10—$6.99

Common questions about Outset Medical

How much does one share of Outset Medical earn?

Over the last 12 months, Outset Medical lost $4.08 for each share on $6.46 of sales.

Does Outset Medical pay a dividend?

Outset Medical didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Outset Medical’s book value per share?

Outset Medical’s book value is $5.13 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Outset Medical have?

Each share of Outset Medical has $1.86 of cash and investments and $5.29 of debt, as of June 30, 2026.

What is Outset Medical’s free cash flow per share?

−$2.13 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Outset Medical bought back shares?

Outset Medical’s share count rose about 400% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.